Gabapentin may treat fibromyalgia pain

Jun 11, 2007

U.S. scientists say the anticonvulsant medication gabapentin might be effective in treating pain and other symptoms arising from fibromyalgia.

The results stem from a randomized, double-blind study of 150 women and men with the condition, sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Dr. Lesley Arnold, director of the Women's Health Research Program at the University of Cincinnati's College of Medicine, and her colleagues found those taking gabapentin at dosages of 1,200 to 2,400 mg daily for 12 weeks displayed significantly less pain than those taking placebo.

Patients taking gabapentin also reported significantly better sleep and less fatigue.

"While gabapentin does not have Food and Drug Administration approval for fibromyalgia, I believe this study offers additional insight to physicians considering the drug for their fibromyalgia patients," said Dr. Stephen Katz, NIAMS director.

Fibromyalgia is a chronic disorder characterized by chronic, widespread muscle pain and tenderness, and is frequently accompanied by fatigue, insomnia, depression, and anxiety. It affects 3 million to 6 million Americans, mostly women, and can be disabling.

The research appeared in the journal Arthritis & Rheumatism.

Copyright 2007 by United Press International

Explore further: Organovo has 3D-printed liver tissue for drug testing

add to favorites email to friend print save as pdf

Related Stories

Microsoft rolls out Skype for web browsers

8 hours ago

Microsoft on Friday released a test version of Skype that lets people make Internet calls from web browsers, eliminating the need to install special applications.

A kingdom of cave beetles found in Southern China

10 hours ago

A team of scientists specializing in cave biodiversity from the South China Agricultural University (Guangzhou) unearthed a treasure trove of rare blind cave beetles. The description of seven new species ...

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

4 hours ago

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.